Business article - March 26, 2024
Braincool reports the ex-CEO to the police
Braincool announces that it is reporting its former CEO to the police over a prohibited loan, and that it will have to raise capital of SEK 85-95 million. The police report comes after ex-CEO Martin Waleij allegedly carried out a falsified payment on his own initiative, which was in fact a loan from the company […]
Biotech Business - March 26, 2024
Neogap awarded Eurostars funding
The company has received SEK 5 million from Eurostars in a collaborative project with the French biotech company Okomera. The funding is intended to strengthen the development of an analysis method for T-cell activity against the patient’s tumor. “We are very grateful for the support from Eurostars, which not only recognizes the scientific potential of […]
Biotech Business - March 25, 2024
DoMore Diagnostics secures EIC Accelerator grant
The company has been awarded up to EUR 10 million in grant and equity financing by the European Innovation Council (EIC) Accelerator program to support the company through key milestones leading to commercial launch and scale-up of its digital biomarker Histotype Px Colorectal. This milestone marks a breakthrough in the company’s journey to ensure personalized […]
Biotech Business - March 14, 2024
Asgard Therapeutics announces EUR 30 million Series A financing
The funds will be used to support development of Asgard’s lead program AT-108 to IND-readiness by 2026, expand and reinforce its research and development team, and fuel new reprogramming modalities and delivery platforms to strengthen the pipeline. “Asgard’s technology overcomes challenges faced by traditional cell therapies, enabling the recreation of desired functional immune cells directly […]
Financing - March 5, 2024
Calmark Sweden files for bankruptcy
The board of Calmark Sweden has decided to file for bankruptcy. The board’s decision is based on the company’s strained and urgent liquidity needs in both the short and long term. In-depth dialogues with intended cooperation partners have not been able to be completed, states the company. The Board of Directors assesses that the warrants […]
Biotech Business - March 4, 2024
Gedea Biotech selected for grant funding from the EIC
The European Innovation Council (EIC) has announced that Gedea Biotech has been selected for the EUR 2.5 million EIC Accelerator grant for the continued development and commercialization of pHyph, an antibiotic free treatment for vaginal infections. The funding will accelerate the development of pHyph, bringing this treatment earlier to patients in need, states Gedea Biotech. […]
